Is RRSSF or JNJ a better dividend investment in 2026?

RRSSF currently yields 3333.33% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: RRSSF offers higher current income.

What is the dividend yield difference between RRSSF and JNJ?

RRSSF has a forward dividend yield of 3333.33% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 3329.97 percentage points.

Home › Compare › RRSSF vs JNJ

RRSSF vs JNJ: Dividend Comparison 2026

RRSSF yields 3333.33% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RRSSF wins by $95.02M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RRSSF

● Live price

3333.33%

Share price

$0.06

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$95.04M

Annual income

$1,547,071.13

Full RRSSF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — RRSSF vs JNJ

📍 RRSSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RRSSF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RRSSF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RRSSF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RRSSF

Annual income on $10K today (after 15% tax)

$283,333.33/yr

After 10yr DRIP, annual income (after tax)

$1,315,010.46/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, RRSSF beats the other by $1,314,306.85/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RRSSF + JNJ for your $10,000?

RRSSF: 50%JNJ: 50%

100% JNJ50/50100% RRSSF

Portfolio after 10yr

$47.53M

Annual income

$773,949.45/yr

Blended yield

1.63%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RRSSF

No analyst data

Altman Z

-0.9

Piotroski

1/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RRSSF buys

JNJ buys

No recent congressional trades found for RRSSF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRRSSFJNJ

Forward yield	3333.33% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	-50%	5.8% ✓
Portfolio after 10y	$95.04M ✓	$20.0K
Annual income after 10y	$1,547,071.13 ✓	$827.78
Total dividends collected	$69.99M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: RRSSF vs JNJ ($10,000, DRIP)

Year	RRSSF Portfolio	RRSSF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$177,367	$166,666.67	$10,676	$355.77	+$166.7K → RRSSF
2	$1,571,143	$1,381,360.33	$11,407	$389.39	+$1.56M → RRSSF
3	$7,399,026	$5,717,903.55	$12,198	$426.53	+$7.39M → RRSSF
4	$20,499,894	$12,582,936.21	$13,056	$467.62	+$20.49M → RRSSF
5	$38,225,794	$16,290,907.46	$13,987	$513.12	+$38.21M → RRSSF
6	$55,096,633	$14,195,032.83	$14,998	$563.56	+$55.08M → RRSSF
7	$68,514,130	$9,560,732.50	$16,098	$619.52	+$68.50M → RRSSF
8	$78,865,738	$5,555,619.33	$17,295	$681.69	+$78.85M → RRSSF
9	$87,374,658	$2,988,318.85	$18,599	$750.82	+$87.36M → RRSSF
10	$95,037,956	$1,547,071.13	$20,022	$827.78	+$95.02M → RRSSF

RRSSF vs JNJ: Complete Analysis 2026

RRSSF — Stock

Neometals Ltd explores for mineral projects in Australia. The company operates through three segments: Lithium, Titanium/Vanadium, and Other. Its projects include the Lithium-ion Battery Recycling project, which recovers cobalt and other materials from spent and scrap lithium batteries; Vanadium Recovery project, which recovers vanadium pentoxide through processing of steelmaking by-products; Lithium Refinery project; and Barrambie Titanium and Vanadium project located in Western Australia. The company was formerly known as Reed Resources Ltd. and changed its name to Neometals Ltd in December 2014. Neometals Ltd was incorporated in 2001 and is based in West Perth, Australia.

Full RRSSF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this RRSSF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RRSSF vs SCHD RRSSF vs JEPI RRSSF vs O RRSSF vs KO RRSSF vs MAIN RRSSF vs ABBV RRSSF vs MRK RRSSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.